• Title Improving tuberculosis diagnosis in vulnerable populations: impact and cost-effectiveness of a novel, rapid molecular assay
  • Granting Agency CIHR (Canadian Institutes of Health Sciences)
  • Period 1 Oct. 2011 – 30 Sept. 2014
  • Amount $355,730 CAD

This study evaluated a new rapid point-of-care molecular assay for the diagnosis of TB in Montreal and Iqaluit.

Publications

Oxlade, Olivia; Sugarman, Jordan; Alvarez, Gonzalo G; Pai, Madhukar; Schwartzman, Kevin

Xpert MTB/RIF for the Diagnosis of Tuberculosis in a Remote Arctic Setting: Impact on Cost and Time to Treatment Initiation (Journal Article)

In: PLoS One, vol. 11, no. 3, pp. e0150119, 2016.

(Links)

Alvarez, Gonzalo G; Dyk, Deborah D Van; Desjardins, Marc; Yasseen, Abdool S; Aaron, Shawn D; Cameron, D William; Obed, Natan; Baikie, Maureen; Pakhale, Smita; Denkinger, Claudia M; others,

The feasibility, accuracy, and impact of Xpert MTB/RIF testing in a remote aboriginal community in Canada (Journal Article)

In: Chest, vol. 148, no. 3, pp. 767–773, 2015.

(Links)

Schumacher, SG; Thangakunam, B; Denkinger, CM; Oliver, AA; Shakti, KB; Qin, ZZ; Michael, JS; Luo, R; Pai, M; Christopher, DJ

Impact of point-of-care implementation of Xpert MTB/RIF: product vs. process innovation (Journal Article)

In: The International Journal of Tuberculosis and Lung Disease, vol. 19, no. 9, pp. 1084–1090, 2015.

(Links)

Sohn, Hojoon; Aero, Abebech D; Menzies, Dick; Behr, Marcel; Schwartzman, Kevin; Alvarez, Gonzalo G; Dan, Andrei; McIntosh, Fiona; Pai, Madhukar; Denkinger, Claudia M

Xpert MTB/RIF testing in a low TB incidence, high-resource setting: limitations in accuracy and clinical impact (Journal Article)

In: Clinical infectious diseases, pp. ciu022, 2014.

(Links)